Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2004-002408-13 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Type IIb dyslipidemia is characterized by elevated triglycerides (TG ³ 150 mg/dL), and elevated LDL-C levels (³160 mg/dL). When in addition, HDL-C is low, the presence of the lipid triad, elevated TG and LDL-C and low levels of HDL-C, seems to confer additional CHD risk in this type of patient, compared to elevated LDL-C alone.Coadministration of fenofibrate and ezetimibe could provide a complementary efficacy therapy and improve the atherogenic profile of this patient population.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Combination of 145 mg fenofibrate and 10 mg ezetimibe | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| TG and HDL-C levels. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Global Clinical Director Solvay | Solvay Pharmaceuticals | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Site 113 | Charleroi | Belgium | ||||
| Site 111 |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 19331437 | Derived | Ansquer JC, Bekaert I, Guy M, Hanefeld M, Simon A; Study Investigators. Efficacy and safety of coadministration of fenofibrate and ezetimibe compared with each as monotherapy in patients with type IIb dyslipidemia and features of the metabolic syndrome: a prospective, randomized, double-blind, three-parallel arm, multicenter, comparative study. Am J Cardiovasc Drugs. 2009;9(2):91-101. doi: 10.1007/BF03256580. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Comines |
| Belgium |
| Site 112 | Couillet | Belgium |
| Site 115 | Dessel | Belgium |
| Site 114 | Dour | Belgium |
| Site 106 | Genk | Belgium |
| Site 102 | Genly | Belgium |
| Site 109 | Kortessem | Belgium |
| Site 104 | Kortrijk | Belgium |
| Site 108 | Liège | Belgium |
| Site 107 | Menen | Belgium |
| Site 105 | Moen | Belgium |
| Site 101 | Oosteeklo | Belgium |
| Site 110 | Oostham | Belgium |
| Site 116 | Seraing | Belgium |
| Site 103 | Turnhout | Belgium |
| Site 213 | Bondy | France |
| Site 211 | Le Beausset | France |
| Site 209 | Nantes | France |
| Site 202 | Orvault | France |
| Site 206 | Paris | France |
| Site 208 | Paris | France |
| Site 212 | Paris | France |
| Site 201 | Saint Sébastian Sur Loire | France |
| Site 205 | Saint Sébastian Sur Loire | France |
| Site 207 | Saint Sébastian Sur Loire | France |
| Site 203 | Saint-Cyr | France |
| Site 210 | Six-Fours-les-Plages | France |
| Site 204 | Toulon | France |
| Site 313 | Borna | Germany |
| Site 307 | Bretten | Germany |
| Site 306 | Dresden | Germany |
| Site 305 | Erbach im Odenwald | Germany |
| Site 304 | Frankfurt | Germany |
| Site 308 | Frankfurt | Germany |
| Site 311 | Frankfurt | Germany |
| Site 301 | Ilvesheim | Germany |
| Site 302 | Leipzig | Germany |
| Site 303 | Leipzig | Germany |
| Site 314 | Mannheim | Germany |
| Site 309 | Offenbach | Germany |
| Site 312 | Offenbach | Germany |
| Site 310 | Rodgau | Germany |
| ID | Term |
|---|---|
| D011345 | Fenofibrate |
| D000069438 | Ezetimibe |
| ID | Term |
|---|---|
| D058607 | Fibric Acids |
| D058610 | Isobutyrates |
| D002087 | Butyrates |
| D000144 | Acids, Acyclic |
| D002264 | Carboxylic Acids |
| D009930 | Organic Chemicals |
| D010647 | Phenyl Ethers |
| D004987 | Ethers |
| D001577 | Benzophenones |
| D001555 | Benzene Derivatives |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |
| D010636 | Phenols |
| D007659 | Ketones |
| D001384 | Azetidines |
| D001385 | Azetines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided